{"id":236139,"date":"2021-03-15T09:13:36","date_gmt":"2021-03-15T13:13:36","guid":{"rendered":"https:\/\/oncubanews.com\/en\/?p=236139"},"modified":"2021-03-15T09:13:36","modified_gmt":"2021-03-15T13:13:36","slug":"minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial","status":"publish","type":"post","link":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/","title":{"rendered":"Minimal adverse effects from Soberana 02 reported after first week of Phase III trial"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">After the first week of the phase III clinical trial of the Soberana 02 <\/span><a href=\"https:\/\/oncubanews.com\/en\/tag\/cuban-vaccine-against-covid-19\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">vaccine candidate<\/span><\/a><span style=\"font-weight: 400;\">, \u201conly some mild adverse effects and general discomfort are reported,\u201d after vaccinating 4,478 volunteers in Havana, reported this Saturday the Biotechnology and Pharmaceutical Industries of Cuba Business Group (BioCubafarma).<\/span><\/p>\n<p><span style=\"font-weight: 400;\">At the end of Friday, the study was carried out in 40 vaccination centers, a figure that should increase in the coming days in the municipalities of the Cuban capital selected for the trial, the state entity said on its Twitter account.<\/span><\/p>\n<blockquote class=\"twitter-tweet\">\n<p dir=\"ltr\" lang=\"es\">Al cierre del viernes 12 de marzo est\u00e1n funcionales 40 vacunatorios, los que deben incrementarse en los pr\u00f3ximos d\u00edas en los municipios que forman parte del ensayo. &#x1f447;<\/p>\n<p>\u2014 BioCubaFarma (@BioCubaFarma) <a href=\"https:\/\/twitter.com\/BioCubaFarma\/status\/1370767448593502210?ref_src=twsrc%5Etfw\">March 13, 2021<\/a><\/p><\/blockquote>\n<blockquote class=\"twitter-tweet\">\n<p dir=\"ltr\" lang=\"es\">Esta primera semana de pilotaje y ajuste de los procesos, cierra con 4478 vacunados. Solo se reportan algunos efectos adversos leves y malestar general. (Fin). <a href=\"https:\/\/twitter.com\/hashtag\/VacunasCubanasCovid19?src=hash&amp;ref_src=twsrc%5Etfw\">#VacunasCubanasCovid19<\/a> en <a href=\"https:\/\/twitter.com\/hashtag\/CubaPorLaVida?src=hash&amp;ref_src=twsrc%5Etfw\">#CubaPorLaVida<\/a><\/p>\n<p>\u2014 BioCubaFarma (@BioCubaFarma) <a href=\"https:\/\/twitter.com\/BioCubaFarma\/status\/1370768120663715841?ref_src=twsrc%5Etfw\">March 13, 2021<\/a><\/p><\/blockquote>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p><span style=\"font-weight: 400;\">In the first week of \u201cpiloting and adjusting\u201d the processes of the third phase with the <\/span><a href=\"https:\/\/oncubanews.com\/en\/coronavirus\/\"><span style=\"font-weight: 400;\">COVID-19<\/span><\/a><span style=\"font-weight: 400;\"> drug, the established protocol and good clinical practices have been strictly complied with, indicated the information, cited by the <\/span><a href=\"http:\/\/www.acn.cu\/salud\/77692-actualizan-resultados-de-soberana-02-durante-primera-semana-de-ensayos-clinicos\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Agencia Cubana de Noticias<\/span><\/a><span style=\"font-weight: 400;\"> news agency.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Soberana 02 began its clinical trials in October 2020, two months later it advanced to the second phase of the study and, after obtaining and demonstrating good immunogenicity results, it received authorization to begin the definitive stage of the vaccine candidate.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Doses of the drug are currently being administered to volunteers between 19 and 80 years of age,<\/span><span style=\"font-weight: 400;\"> to identify the presence of neutralizing antibodies to the virus that causes COVID-19, according to the source.<\/span><\/p>\n<p>https:\/\/twitter.com\/BioCubaFarma\/status\/1370767136747044872?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1370767136747044872%7Ctwgr%5E%7Ctwcon%5Es1_&#038;ref_url=https%3A%2F%2Foncubanews.com%2Fcuba%2Freportan-minimos-efectos-adversos-a-soberana-02-tras-primera-semana-del-ensayo-fase-iii%2F<\/p>\n<p><span style=\"font-weight: 400;\">Cuba intends to immunize its entire population against the coronavirus this year and its biopharmaceutical industry is developing <\/span><a href=\"https:\/\/oncubanews.com\/en\/tag\/cuban-vaccine-against-covid-19\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">five vaccine candidates<\/span><\/a><span style=\"font-weight: 400;\">: Soberana 01, Soberana 02, Abdala, Mambisa, and Soberana Plus, the latter recently presented and intended for convalescents from COVID-19 and as booster doses to other vaccines.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This week the island sent 100,000 doses of Soberana 02, the most advanced of these drugs, to <\/span><a href=\"https:\/\/oncubanews.com\/tag\/iran\/?amp\"><span style=\"font-weight: 400;\">Iran<\/span><\/a><span style=\"font-weight: 400;\"> to also carry out the third phase of the clinical trial in that country, where the effectiveness of the Cuban formula will be tested, official sources reported this Friday.<\/span><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"E9z9yRvuny\"><p><a href=\"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/cuba-sends-100000-doses-of-the-soberana-02-vaccine-candidate-to-iran\/\">Cuba sends 100,000 doses of the Soberana 02 vaccine candidate to Iran<\/a><\/p><\/blockquote>\n<p><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Cuba sends 100,000 doses of the Soberana 02 vaccine candidate to Iran&#8221; &#8212; OnCubaNews English\" src=\"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/cuba-sends-100000-doses-of-the-soberana-02-vaccine-candidate-to-iran\/embed\/#?secret=d9fj844t7k#?secret=E9z9yRvuny\" data-secret=\"E9z9yRvuny\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p><span style=\"font-weight: 400;\">BioCubafarma announced on Twitter the sending of the doses \u201cas part of the collaboration with other countries in the development of COVID-19 vaccines.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cA total of 100,000 doses of Soberana 02 were sent to the Pasteur Institute in Iran, which will be used in clinical trials in that country,\u201d said that business group.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>At the end of Friday, the study was carried out in 40 vaccination centers, a figure that should increase in the coming days, in the municipalities of the Cuban capital selected for the trial.<\/p>\n","protected":false},"author":3134,"featured_media":236140,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13916],"tags":[32932,15273,33462],"ppma_author":[33546],"class_list":["post-236139","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science-in-cuba","tag-cuban-medicine-against-covid-19","tag-cuban-science","tag-soberana-02"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Minimal adverse effects from Soberana 02 reported after first week of Phase III trial | OnCubaNews English<\/title>\n<meta name=\"description\" content=\"At the end of Friday, the study was carried out in 40 vaccination centers, a figure that should increase in the coming days, in the municipalities of the Cuban capital selected for the trial.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Minimal adverse effects from Soberana 02 reported after first week of Phase III trial | OnCubaNews English\" \/>\n<meta property=\"og:description\" content=\"At the end of Friday, the study was carried out in 40 vaccination centers, a figure that should increase in the coming days, in the municipalities of the Cuban capital selected for the trial.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"OnCubaNews English\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-15T13:13:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/03\/Soberana-02-Instituto-Finlay-de-Vacunas-750x536-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"750\" \/>\n\t<meta property=\"og:image:height\" content=\"536\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"OnCuba Staff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"OnCuba Staff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/\"},\"author\":{\"name\":\"OnCuba Staff\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/d7171bf311032ab1f557dd8332e714af\"},\"headline\":\"Minimal adverse effects from Soberana 02 reported after first week of Phase III trial\",\"datePublished\":\"2021-03-15T13:13:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/\"},\"wordCount\":451,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Soberana-02-Instituto-Finlay-de-Vacunas-750x536-1.jpg\",\"keywords\":[\"Cuban medicine against COVID-19\",\"Cuban science\",\"Soberana 02\"],\"articleSection\":[\"Science in Cuba\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/#respond\"]}],\"copyrightYear\":\"2021\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/\",\"name\":\"Minimal adverse effects from Soberana 02 reported after first week of Phase III trial | OnCubaNews English\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Soberana-02-Instituto-Finlay-de-Vacunas-750x536-1.jpg\",\"datePublished\":\"2021-03-15T13:13:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/d7171bf311032ab1f557dd8332e714af\"},\"description\":\"At the end of Friday, the study was carried out in 40 vaccination centers, a figure that should increase in the coming days, in the municipalities of the Cuban capital selected for the trial.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/#primaryimage\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Soberana-02-Instituto-Finlay-de-Vacunas-750x536-1.jpg\",\"contentUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Soberana-02-Instituto-Finlay-de-Vacunas-750x536-1.jpg\",\"width\":750,\"height\":536,\"caption\":\"Photo: @FinlayInstituto\\\/Twitter.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/science-cuba\\\/science-in-cuba\\\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Minimal adverse effects from Soberana 02 reported after first week of Phase III trial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/\",\"name\":\"OnCubaNews English\",\"description\":\"Revista sobre Cuba\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/d7171bf311032ab1f557dd8332e714af\",\"name\":\"OnCuba Staff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g17310096d4dde63ebae0e54fbb19218a\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g\",\"caption\":\"OnCuba Staff\"},\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/author\\\/oncuba-editorial-staff\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Minimal adverse effects from Soberana 02 reported after first week of Phase III trial | OnCubaNews English","description":"At the end of Friday, the study was carried out in 40 vaccination centers, a figure that should increase in the coming days, in the municipalities of the Cuban capital selected for the trial.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/","og_locale":"en_US","og_type":"article","og_title":"Minimal adverse effects from Soberana 02 reported after first week of Phase III trial | OnCubaNews English","og_description":"At the end of Friday, the study was carried out in 40 vaccination centers, a figure that should increase in the coming days, in the municipalities of the Cuban capital selected for the trial.","og_url":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/","og_site_name":"OnCubaNews English","article_published_time":"2021-03-15T13:13:36+00:00","og_image":[{"width":750,"height":536,"url":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/03\/Soberana-02-Instituto-Finlay-de-Vacunas-750x536-1.jpg","type":"image\/jpeg"}],"author":"OnCuba Staff","twitter_card":"summary_large_image","twitter_misc":{"Written by":"OnCuba Staff","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/#article","isPartOf":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/"},"author":{"name":"OnCuba Staff","@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/d7171bf311032ab1f557dd8332e714af"},"headline":"Minimal adverse effects from Soberana 02 reported after first week of Phase III trial","datePublished":"2021-03-15T13:13:36+00:00","mainEntityOfPage":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/"},"wordCount":451,"commentCount":0,"image":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/#primaryimage"},"thumbnailUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/03\/Soberana-02-Instituto-Finlay-de-Vacunas-750x536-1.jpg","keywords":["Cuban medicine against COVID-19","Cuban science","Soberana 02"],"articleSection":["Science in Cuba"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/#respond"]}],"copyrightYear":"2021","copyrightHolder":{"@id":"https:\/\/oncubanews.com\/en\/#organization"}},{"@type":"WebPage","@id":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/","url":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/","name":"Minimal adverse effects from Soberana 02 reported after first week of Phase III trial | OnCubaNews English","isPartOf":{"@id":"https:\/\/oncubanews.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/#primaryimage"},"image":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/#primaryimage"},"thumbnailUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/03\/Soberana-02-Instituto-Finlay-de-Vacunas-750x536-1.jpg","datePublished":"2021-03-15T13:13:36+00:00","author":{"@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/d7171bf311032ab1f557dd8332e714af"},"description":"At the end of Friday, the study was carried out in 40 vaccination centers, a figure that should increase in the coming days, in the municipalities of the Cuban capital selected for the trial.","breadcrumb":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/#primaryimage","url":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/03\/Soberana-02-Instituto-Finlay-de-Vacunas-750x536-1.jpg","contentUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/03\/Soberana-02-Instituto-Finlay-de-Vacunas-750x536-1.jpg","width":750,"height":536,"caption":"Photo: @FinlayInstituto\/Twitter."},{"@type":"BreadcrumbList","@id":"https:\/\/oncubanews.com\/en\/cuba\/science-cuba\/science-in-cuba\/minimal-adverse-effects-from-soberana-02-reported-after-first-week-of-phase-iii-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/oncubanews.com\/en\/"},{"@type":"ListItem","position":2,"name":"Minimal adverse effects from Soberana 02 reported after first week of Phase III trial"}]},{"@type":"WebSite","@id":"https:\/\/oncubanews.com\/en\/#website","url":"https:\/\/oncubanews.com\/en\/","name":"OnCubaNews English","description":"Revista sobre Cuba","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oncubanews.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/d7171bf311032ab1f557dd8332e714af","name":"OnCuba Staff","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g17310096d4dde63ebae0e54fbb19218a","url":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g","caption":"OnCuba Staff"},"url":"https:\/\/oncubanews.com\/en\/author\/oncuba-editorial-staff\/"}]}},"authors":[{"term_id":33546,"user_id":3134,"is_guest":0,"slug":"oncuba-editorial-staff","display_name":"OnCuba Staff","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts\/236139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/users\/3134"}],"replies":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/comments?post=236139"}],"version-history":[{"count":0,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts\/236139\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/media\/236140"}],"wp:attachment":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/media?parent=236139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/categories?post=236139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/tags?post=236139"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/ppma_author?post=236139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}